204 filings
Page 7 of 11
8-K
cusjk
25 Nov 05
Other Events
12:00am
8-K
xyhwr9
16 Nov 05
OSI Pharmaceuticals Completes Its Acquisition of Eyetech Pharmaceuticals
12:00am
8-K
luyi2ojxi64k
15 Nov 05
Regulation FD Disclosure
12:00am
8-K
xjn l6qc39a
14 Nov 05
Other Events
12:00am
8-K
gct9ez6sj476kv
14 Nov 05
Regulation FD Disclosure
12:00am
8-K
ilmgy
10 Nov 05
OSI Pharmaceuticals Updates Status of Pending Acquisition of Eyetech Pharmaceuticals
12:00am
8-K
3mo5lf1bkg0y0b6x
9 Nov 05
Other Events
12:00am
8-K
jjjci8kr ba
3 Nov 05
Osi Pharmaceuticals Announces Third Quarter Financial Results
12:00am
8-K
h4quj2uh
31 Oct 05
Entry into a Material Definitive Agreement
12:00am
8-K
306p9 ej8ew06p95
20 Oct 05
Other Events
12:00am
8-K
r20yol3obynf1
13 Oct 05
Other Events
12:00am
8-K
v8n7a
11 Oct 05
Other Events
12:00am
8-K
psmz91ug
26 Sep 05
FDA Advisory Panel Recommends Tarceva(R) Approval for Pancreatic Cancer; Committee Supports New Indication for EGFR Inhibitor Tarceva
12:00am
8-K
rimjshe7s1 ieh9z
2 Sep 05
Other Events
12:00am
8-K
wj0qy d7in
22 Aug 05
Entry into a Material Definitive Agreement
12:00am
8-K
bc1w11ajmo sb
19 Aug 05
Other Events
12:00am
8-K
mtiaj0cl16t462lj
2 Aug 05
Results of Operations and Financial Condition
12:00am
8-K
aiqpoyqt k4
12 Jul 05
Other Events
12:00am
8-K
tu7tmw11u7xtpm5
12 Jul 05
Other Events
12:00am
8-K
3ckc96l fp2
17 Jun 05
OSI Pharmaceuticals Announces Issuance of Additional U.S. Patent for Tarceva; Extends Patent Exclusivity
12:00am